Lyra Therapeutics Statistics
Total Valuation
LYRA has a market cap or net worth of $7.58 million. The enterprise value is $10.27 million.
Important Dates
The last earnings date was Friday, November 7, 2025, after market close.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
LYRA has 1.64 million shares outstanding. The number of shares has increased by 6.46% in one year.
| Current Share Class | 1.64M |
| Shares Outstanding | 1.64M |
| Shares Change (YoY) | +6.46% |
| Shares Change (QoQ) | +2.55% |
| Owned by Insiders (%) | 1.39% |
| Owned by Institutions (%) | 7.98% |
| Float | 1.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.91 |
| Forward PS | 12.58 |
| PB Ratio | 4.62 |
| P/TBV Ratio | 4.67 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 13.34 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.78, with a Debt / Equity ratio of 20.02.
| Current Ratio | 2.78 |
| Quick Ratio | 2.67 |
| Debt / Equity | 20.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -238.26% and return on invested capital (ROIC) is -43.93%.
| Return on Equity (ROE) | -238.26% |
| Return on Assets (ROA) | -30.40% |
| Return on Invested Capital (ROIC) | -43.93% |
| Return on Capital Employed (ROCE) | -86.42% |
| Revenue Per Employee | $25,667 |
| Profits Per Employee | -$1.29M |
| Employee Count | 30 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, LYRA has paid $19,000 in taxes.
| Income Tax | 19,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -67.06% in the last 52 weeks. The beta is -0.04, so LYRA's price volatility has been lower than the market average.
| Beta (5Y) | -0.04 |
| 52-Week Price Change | -67.06% |
| 50-Day Moving Average | 6.59 |
| 200-Day Moving Average | 7.95 |
| Relative Strength Index (RSI) | 25.80 |
| Average Volume (20 Days) | 27,225 |
Short Selling Information
The latest short interest is 37,933, so 2.31% of the outstanding shares have been sold short.
| Short Interest | 37,933 |
| Short Previous Month | 24,582 |
| Short % of Shares Out | 2.31% |
| Short % of Float | 3.38% |
| Short Ratio (days to cover) | 0.88 |
Income Statement
In the last 12 months, LYRA had revenue of $770,000 and -$38.84 million in losses. Loss per share was -$29.40.
| Revenue | 770,000 |
| Gross Profit | -21.48M |
| Operating Income | -35.79M |
| Pretax Income | -38.82M |
| Net Income | -38.84M |
| EBITDA | -35.34M |
| EBIT | -35.79M |
| Loss Per Share | -$29.40 |
Full Income StatementBalance Sheet
The company has $29.78 million in cash and $32.48 million in debt, giving a net cash position of -$2.69 million or -$1.64 per share.
| Cash & Cash Equivalents | 29.78M |
| Total Debt | 32.48M |
| Net Cash | -2.69M |
| Net Cash Per Share | -$1.64 |
| Equity (Book Value) | 1.62M |
| Book Value Per Share | 1.00 |
| Working Capital | 19.90M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$43.01 million and capital expenditures -$13,000, giving a free cash flow of -$43.02 million.
| Operating Cash Flow | -43.01M |
| Capital Expenditures | -13,000 |
| Free Cash Flow | -43.02M |
| FCF Per Share | -$26.16 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -4,647.79% |
| Pretax Margin | -5,041.17% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LYRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.46% |
| Shareholder Yield | -6.46% |
| Earnings Yield | -512.29% |
| FCF Yield | -567.48% |
Analyst Forecast
The average price target for LYRA is $16.00, which is 247.07% higher than the current price. The consensus rating is "Hold".
| Price Target | $16.00 |
| Price Target Difference | 247.07% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 111.93% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 28, 2025. It was a reverse split with a ratio of 1:50.
| Last Split Date | May 28, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:50 |
Scores
LYRA has an Altman Z-Score of -12.82 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.82 |
| Piotroski F-Score | 1 |
